Skip to main content
Clinical Trials/NCT01672190
NCT01672190CompletedNot Applicable

Lessening Incontinence by Learning Yoga

University of California, San Francisco1 site in 1 country20 target enrollmentStarted: August 1, 2012Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
20
Locations
1
Primary Endpoint
Change in the number of incontinence episodes over 7 days, with 95% confidence intervals, between baseline and 6 weeks

Study Overview

Brief Summary

The purpose of this study is to assess the feasibility of recruiting women with urinary incontinence into a randomized controlled trial of a yoga therapy program.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Single Group
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
40 Years to — (Adult, Older Adult)
Sex
Female
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •Women aged 40 years or older who report urinary incontinence for > 3 months prior to screening
  • •Self-report at least 7 urinary incontinence episodes per week on a screening 7-day voiding diary
  • •Self-report urgency-predominant, stress-predominant, or mixed-type incontinence on the screening voiding diary
  • •Willing to refrain from initiating medical treatments that may affect their incontinence or voiding pattern during the study period
  • •Capable of understanding study procedures and giving informed consent

Exclusion Criteria

  • •Participation in a yoga class or other formal or organized yoga instruction in the past year
  • •Any prior yoga therapy directed specifically at improving urinary incontinence or pelvic floor dysfunction
  • •Current use of medical therapy or device (i.e. pessary) for incontinence or use within the previous month
  • •Currently pregnant, gave birth within the past 6 months, or planning pregnancy during the study period
  • •Current urinary tract infection or a history or 3 or more urinary tract infections in the preceding year
  • •Report history of neurologic conditions such as stroke, multiple sclerosis, spinal cord injury, or Parkinson's disease, or a lumbosacral spine condition associated with neurological symptoms
  • •Unable to walk up a flight of stairs or at least 2 blocks on level ground without assistance
  • •Unable to get up from a supine to a standing position in 10 seconds or less and without assistance
  • •Severe obesity, defined as body mass index > 35 kg/m2 on screening examination
  • •Report history of interstitial cystitis, fistula or hole in bladder or rectum, or birth defect leading to urine leakage
  • •Report any history of prior anti-incontinence or urethral surgery (not including urethral dilation), pelvic cancer, or pelvic irradiation for any reason
  • •Report use of bladder botox, electrostimulation, bladder training, or pelvic floor exercise training (with certified practitioners) in the past 3 months
  • •Report other surgery to the pelvis (hysterectomy, oophorectomy, vaginal surgery, bladder surgery, colon surgery) within the past 3 months
  • •Report symptomatic pelvic organ prolapse
  • •Report history of vulvodynia, chronic pelvic pain, or pain when practicing pelvic floor exercises
  • •Report conditions that, in the judgment of the investigators, render potential participants unlikely to follow the protocol, including plans to move, substance abuse, significant psychiatric problems, or dementia
  • •Participation in another research study that involves investigational drugs or devices that could potentially confound the results of this study

Arms & Interventions

Yoga Therapy

Experimental

Women in the Yoga Therapy Group will receive twice weekly yoga classes for 6 weeks.

Intervention: Yoga Therapy Program (Other)

Control

No Intervention

Women in the Control Group will wait 6 weeks before receiving a gift certificate for yoga classes at an external yoga studio in the San Francisco Bay Area

Outcomes

Primary Outcomes

Change in the number of incontinence episodes over 7 days, with 95% confidence intervals, between baseline and 6 weeks

Time Frame: 6 weeks

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Alison Huang

Assistant Professor

University of California, San Francisco

Study Sites (1)

Loading locations...

Similar Trials